A Study of Alpelisib and Fulvestrant to Treat Endometrial Cancer

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Study of Alpelisib and Fulvestrant to Treat Endometrial Cancer	Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence	Active, not recruiting	Phase 2	2026-07-30		NCT05154487

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
GOG Foundation	38
Novartis	114

21 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
AdventHealth Gynecologic Oncology	Orlando	United States	2
Ascension St. Vincent	Indianapolis	United States	11
City of Hope	Duarte	United States	238
Endeavor Health	Evanston	United States	30
Endeavor Health Clinical Operations, Glenbrook Hospital	Glenview	United States	1
Endeavor Health Clinical Operations, Highland Park Hospital	Highland Park	United States	1
Johns Hopkins Medicine	Baltimore	United States	14
Kettering Health Cancer Center	Kettering	United States	3
Legacy Good Samaritan Medical Center	Portland	United States	5
Legacy Meridian Park Medical Center	Tualatin	United States	2
Legacy Salmon Creek Medical Center	Vancouver	United States	3
Moffit Cancer Center at International Plaza	Tampa	United States	1
Moffit Cancer Center at Wesley Chapel	Wesley Chapel	United States	1
Moffitt Cancer Center	Tampa	United States	523
Mount Sinai Medical Center	Miami Beach	United States	116
Northwell Health Cancer Institute	Lake Success	United States	11
Norton Cancer Institute	Louisville	United States	8
Oklahoma Cancer Specialists and Research Institute, LLC	Tulsa	United States	6
QCC- Northwell Health Physicians Partners Medical	Rego Park	United States	1
Tampa General Hospital	Tampa	United States	128
University of Wisconsin Clinical Science Center	Madison	United States	14

Clinical trials